List view / Grid view

Gastrointestinal stromal tumours (GIST)



Targeting phosphodiesterase 3A: discovery of a promising cancer therapy

22 June 2021 | By , ,

A new promising sarcoma target, phosphodiesterase 3A (PDE3A), and drugs targeting it have been identified by researchers at the University of Helsinki. Dr Katja Ivanitskiy, Dr Harri Sihto and Professor Olli Kallioniemi outline emerging evidence that indicates PDE3A protein-targeting compounds may induce sarcoma cell death by acting as a molecular…